Genitourinary Cancers

Latest News

Treatment with immune checkpoint inhibitors does not raise any new safety signals among patients with locally advanced or metastatic penile squamous cell carcinoma in an international cohort study.
ICIs Demonstrate Clinical Activity in Metastatic Penile Cancer

August 14th 2023

Treatment with immune checkpoint inhibitors does not raise any new safety signals among patients with locally advanced or metastatic penile squamous cell carcinoma in an international cohort study.

Erdafitinib in the Treatment of Metastatic Urothelial Carcinoma
Erdafitinib in the Treatment of Metastatic Urothelial Carcinoma

June 23rd 2023

Management of Testicular Germ Cell Tumor With Somatic-Type Malignancy
Management of Testicular Germ Cell Tumor With Somatic-Type Malignancy

June 15th 2022

2022 Genitourinary Cancers Symposium 2-Minute Drill: Experts Review Most Impactful Data
2022 Genitourinary Cancers Symposium 2-Minute Drill: Experts Review Most Impactful Data

April 20th 2022

CancerNetwork® Recaps Gong’s Twitter Takeover at ASCO GU 2022
CancerNetwork® Recaps Gong’s Twitter Takeover at ASCO GU 2022

February 28th 2022

Video Series
Video Interviews
Podcasts
Lead author, Quirin Zangl, MD, spoke with CancerNetwork about research published in the journal ONCOLOGY focusing on the importance comprehensive geriatric assessment tools for patients with genitourinary carcinomas.
Latest CME Events & Activities

Oncology Town Hall™: Primary Investigators Present Key Abstracts in Genitourinary Malignancies from Paris

View More

40th Annual CFS®: Innovative Cancer Therapy for Tomorrow®

View More

Equalizing Inequities™ in Multiple Myeloma Care: Shining a Light on Current Barriers and Opportunities for Improved Outcomes

View More

Expert Perspectives on Emerging CDK4/6 Inhibitor Strategies in Advanced Prostate Cancer Management Settings

View More

Medical Crossfire®: Why is PSMA so Effective? To Affinity and Beyond

View More

Medical Crossfire®: Expert Exchanges to Maximize Clinical Outcomes for Patients with CRPC Through Evidence-Based Personalized Therapy

View More

Everything You Need to Know About PARP Inhibitor Combinations in Prostate Cancer Care: Why? For Whom? And When?

View More

Advances In™: Targeting PSMA to Advance Diagnosis And Management Of Patients With Prostate Cancer

View More

Clinical Case Vignette Series: Integrating Recent Data into Practice to Improve Outcomes in Advanced Prostate Cancer

View More

Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?

View More

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

More News